Table 1 Characteristics of the entire cohort.
Characteristics | |
|---|---|
Median age, years (range) | 66 (21–83) |
Sex, n (%) | |
Male | 92 (76.0) |
Female | 29 (24.0) |
Histopathology, n (%) | |
Clear cell RCC | 110 (91.0) |
Non-clear cell RCC | 11 (9.0) |
IMDC risk, n (%) | |
Favorable | 21 (17.4) |
Intermediate | 74 (61.2) |
Poor | 26 (21.5) |
Number of metastatic organs, n (%) | |
Single | 55 (45.5) |
Multiple | 66 (54.5) |
Metastatic site | |
Bone | 31 (25.6) |
Lung | 83 (68.6) |
Liver | 17 (14.0) |
Lymph nodes | 47 (38.8) |
Brain | 4 (3.3) |
Confirmation of tissue type, n (%) | |
Nephrectomy | 74 (61.2) |
Biopsy | 33 (27.3) |
Unknown | 4 (3.3) |
Treatment line, n (%) | |
1st | 90 (74.4) |
2nd | 15 (12.4) |
3rd | 6 (6.7) |
≥4th | 10 (11.1) |
CRP, n (%) | |
Low (<1.0) | 71 (58.7) |
High (≥1.0) | 43 (35.5) |
Unknown | 7 (5.8) |
